Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression | Zendy

Federico Pulido | Zendy; Rafaël Delgado | Zendy; Ignacio Valero | Zendy; Juan GonzálezGarcía | Zendy; Pilar Miralles | Zendy; Alberto Arranz | Zendy; Asunción Hernando | Zendy; José Ramón Arribas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression

Author(s) -

Federico Pulido,

Rafaël Delgado,

Ignacio Valero,

Juan GonzálezGarcía,

Pilar Miralles,

Alberto Arranz,

Asunción Hernando,

José Ramón Arribas

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn103

Subject(s) - lopinavir , lopinavir/ritonavir , ritonavir , medicine , human immunodeficiency virus (hiv) , randomized controlled trial , clinical trial , term (time) , pharmacology , virology , antiretroviral therapy , viral load , physics , quantum mechanics

Data are scarce on the long-term efficacy of lopinavir/ritonavir monotherapy for the maintenance of HIV suppression. Four years of results of patients randomized to monotherapy in the Only Kaletra (OK) pilot clinical trial are presented.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research